These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Aberrant expression of long noncoding RNAs in early diabetic retinopathy. Yan B; Tao ZF; Li XM; Zhang H; Yao J; Jiang Q Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):941-51. PubMed ID: 24436191 [TBL] [Abstract][Full Text] [Related]
3. Altered Expression Profile of Circular RNAs in the Serum of Patients with Diabetic Retinopathy Revealed by Microarray. Gu Y; Ke G; Wang L; Zhou E; Zhu K; Wei Y Ophthalmic Res; 2017; 58(3):176-184. PubMed ID: 28817829 [TBL] [Abstract][Full Text] [Related]
4. Risk factors associated with diabetic retinopathy among type 2 diabetes patients at teaching hospital in Malaysia. Abougalambou SS; Abougalambou AS Diabetes Metab Syndr; 2015; 9(2):98-103. PubMed ID: 25470640 [TBL] [Abstract][Full Text] [Related]
5. Potential Diagnostic Biomarkers of tRNA-Derived Small RNAs in PBMCs for Nonproliferative Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus. Ding C; Wang N; Peng A; Wang Z; Li B; Zhang X; Zeng J; Zhou Y Transl Vis Sci Technol; 2024 Aug; 13(8):32. PubMed ID: 39167377 [TBL] [Abstract][Full Text] [Related]
6. Verification of multimarkers for detection of early stage diabetic retinopathy using multiple reaction monitoring. Kim K; Kim SJ; Han D; Jin J; Yu J; Park KS; Yu HG; Kim Y J Proteome Res; 2013 Mar; 12(3):1078-89. PubMed ID: 23368427 [TBL] [Abstract][Full Text] [Related]
7. Factors associated with changes in endothelin-1 gene expression in patients with diabetic retinopathy in type 2 diabetes mellitus. Strzalka-Mrozik B; Nowak A; Gola J; Kowalczyk M; Kapral M; Mazurek U Mol Vis; 2010 Jul; 16():1272-9. PubMed ID: 20664700 [TBL] [Abstract][Full Text] [Related]
8. Genome-wide analysis of DNA methylation identifies S100A13 as an epigenetic biomarker in individuals with chronic (≥ 30 years) type 2 diabetes without diabetic retinopathy. Li T; Xu Y; Shi Y; Chen J; Lin S; Zhu J; Xu X; Lu L; Zou H Clin Epigenetics; 2020 Jun; 12(1):77. PubMed ID: 32493412 [TBL] [Abstract][Full Text] [Related]
9. Time-dependent reduction of glutamine synthetase in retina of diabetic rats. Yu XH; Zhang H; Wang YH; Liu LJ; Teng Y; Liu P Exp Eye Res; 2009 Dec; 89(6):967-71. PubMed ID: 19699197 [TBL] [Abstract][Full Text] [Related]
10. [Diabetes self-management and its association with diabetic retinopathy in patients with type 2 diabetes]. Li N; Yang XF; Deng Y; Gu H; Ren XT; Xu J; Ma K; Liu NP Zhonghua Yan Ke Za Zhi; 2013 Jun; 49(6):500-6. PubMed ID: 24119962 [TBL] [Abstract][Full Text] [Related]
11. Genetic systems for a new approach to risk of progression of diabetic retinopathy. Pinazo-Durán MD; Zanón-Moreno V; Lleó-Perez A; García-Medina JJ; Galbis-Estrada C; Roig-Revert MJ; Marco-Ramírez C; López-Gálvez M; Dolz-Marco R; Duarte L; Campos Borges C; Salgado-Borges J; Gallego-Pinazo R Arch Soc Esp Oftalmol; 2016 May; 91(5):209-16. PubMed ID: 26948458 [TBL] [Abstract][Full Text] [Related]
12. Altered retinal microRNA expression profiles in early diabetic retinopathy: an in silico analysis. Xiong F; Du X; Hu J; Li T; Du S; Wu Q Curr Eye Res; 2014 Jul; 39(7):720-9. PubMed ID: 24502381 [TBL] [Abstract][Full Text] [Related]
13. Identification of biomarkers associated with immune scores in diabetic retinopathy. Zhang Y; Zhu W; Wang J; Zuo Y Front Endocrinol (Lausanne); 2023; 14():1228843. PubMed ID: 37867507 [TBL] [Abstract][Full Text] [Related]
14. Identification and Validation of Autophagy-Related Genes in Diabetic Retinopathy. Wang N; Wei L; Liu D; Zhang Q; Xia X; Ding L; Xiong S Front Endocrinol (Lausanne); 2022; 13():867600. PubMed ID: 35574010 [TBL] [Abstract][Full Text] [Related]
15. [Changes of plasma endothelin-1 and vascular endothelial growth factor in diabetic retinopathy and the clinical application value thereof]. Zhu H; Shi CH Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(40):2837-9. PubMed ID: 18167288 [TBL] [Abstract][Full Text] [Related]
16. Proteinase and growth factor alterations revealed by gene microarray analysis of human diabetic corneas. Saghizadeh M; Kramerov AA; Tajbakhsh J; Aoki AM; Wang C; Chai NN; Ljubimova JY; Sasaki T; Sosne G; Carlson MR; Nelson SF; Ljubimov AV Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3604-15. PubMed ID: 16186340 [TBL] [Abstract][Full Text] [Related]
17. Transcriptome analysis using next generation sequencing reveals molecular signatures of diabetic retinopathy and efficacy of candidate drugs. Kandpal RP; Rajasimha HK; Brooks MJ; Nellissery J; Wan J; Qian J; Kern TS; Swaroop A Mol Vis; 2012; 18():1123-46. PubMed ID: 22605924 [TBL] [Abstract][Full Text] [Related]
18. Downregulation of circulating miR-320a and target gene prediction in patients with diabetic retinopathy. Prado MSG; de Jesus ML; de Goes TC; Mendonça LSO; Kaneto CM BMC Res Notes; 2020 Mar; 13(1):155. PubMed ID: 32178730 [TBL] [Abstract][Full Text] [Related]